OCT 23, 2020 8:30 AM PDT

FDA Gives Full Approval to Remdesivir to Treat COVID-19

WRITTEN BY: Annie Lennon

The US Food and Drug Administration (FDA) has approved antiviral drug Remdesivir, sold under the name ‘Velkury’, for use in adults and children aged 12 and above to treat COVID-19 infections requiring hospitalization. 

Previously, on May 1, 2020, Remdesivir had been given Emergency Use Authorization (EUA) by the FDA, making it available for the entire population while studies on its overall effectiveness were ongoing. As clinical trials assessing the drug’s safety in children are still underway, the FDA has revised the EUA for the drug to continue being used for hospitalized patients with suspected of lab-confirmed COVID-19 who are under the age of 12 and weigh at least 3.5 kg. 

The drug approval comes after the publication of a recent non-peer-reviewed preprint study by the World Health Organization (WHO) showing that Remdesivir, and three other drugs commonly used to treat COVID-19, had marginal effects on the mortality rate for COVID-19 patients. Causing some to doubt the effectiveness of the drug, Gilead Sciences, the pharmaceuritical company behind Remdesivir, warned that the results from the trials have yet to undergo the review process and thus should not be taken without a pinch of salt. 

Nevertheless, other studies have shown that usage of the drug does have some therapeutic effect. A recent study involving 1,062 volunteers, for example, showed that Remdesivir reduces average recovery times (defined as being discharged from hospital or no longer requiring supplemental oxygen or ongoing medical care) from 15 to 10 days. These results reflect early clinical trial results from both the US and China on the drug’s ability to treat COVID-19. 

Considering all available data, it seems that although Remdesivir has almost no effect on death rates, it has shown to be moderately effective in accelerating recovery times for COVID-19. As such, while it is no ‘cure’, it may nevertheless benefit patients recovering from the virus. 

 

Sources: DWFDAThe New York Times

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
APR 19, 2022
Health & Medicine
Pandemic Creates Opportunity to Study Rare Vaccine Side Effects
APR 19, 2022
Pandemic Creates Opportunity to Study Rare Vaccine Side Effects
The Global Vaccine Data Network (GVDN) is a project conceived over 10 years ago to study vaccine side effects. Back then ...
MAY 06, 2022
Drug Discovery & Development
Scientists discover new methods of production for Sulphur-based medications
MAY 06, 2022
Scientists discover new methods of production for Sulphur-based medications
Modern medicine has drastically changed since humans discovered the first ancient treatment methods. Herbal remedies and ...
MAY 12, 2022
Drug Discovery & Development
Gut Bacteria Composition Predicts Resposnse to Statins
MAY 12, 2022
Gut Bacteria Composition Predicts Resposnse to Statins
The composition of the gut microbiome is predictive of patient responses to statins. The corresponding study was publish ...
JUN 21, 2022
Cell & Molecular Biology
From sample collection straight to RT-qPCR
JUN 21, 2022
From sample collection straight to RT-qPCR
Skip the nucleic acid purification step in your cancer detection workflow. Learn more about how Thermo Fisher Scientific ...
JUN 02, 2022
Coronavirus
Loneliness and social isolation may continue to prolong the COVID-19 pandemic
JUN 02, 2022
Loneliness and social isolation may continue to prolong the COVID-19 pandemic
It has been clear for some time that loneliness and social isolation can lead to increased risks for adverse h ...
JUN 06, 2022
Drug Discovery & Development
Weight loss Surgery Reduces Cancer Risk and Cancer Deaths
JUN 06, 2022
Weight loss Surgery Reduces Cancer Risk and Cancer Deaths
Weight loss achieved via bariatric surgery among adults with obesity is linked to a lower risk of developing cancer and ...
Loading Comments...